Multiple Myeloma with Suspected Non-Secretory Type
Abstract
Multiple Myeloma (MM) is a hematological malignancy characterized by clonal plasma cell in bone marrow that produce
abnormal globulin, which resulted in monoclonal gammopathy. Multiple Myeloma Non-Secretory (MMNS) is a very rare
form of multiple myeloma with monoclonal plasmocytic proliferation in bone marrow supported by clinical manifestation
and radiological findings. However, plasma cells fail to secrete immunoglobulin. A 44-year-old female came to Sardjito
General Hospital with main complaints of weakness and back pain. General weakness and pale palpebral conjunctiva were
6 observed (+/+), liver and spleen were not palpable. Blood test results were as follows: Hb 3.0 g/dL, RBC 1.07 x 10 / μL, WBC
3 3 562 x 10 /μL, PLT 114 x 10 /μL, A/G ratio 1.07, BUN 51.5 mg/dL, creatinine 4.62 mg/dL, and calcium 3.1 mmol/L. Skeletal
survey suggested a multiple osteolytic. Protein electrophoresis revealed hypogammaglobulinemia with no M-spike. There
were 66% of plasma cells in bone marrow. Patient was diagnosed by MMNS. Diagnosis MMNS can be established if clonal
plasmacytes is accompanied with renal insufficiency and hypercalcemia. However, monoclonal gammopathy was not found
in serum protein electrophoresis. A case reported of 44-year-old female diagnosed as MMNS with 'punched out' multiple
osteolytic, increased plasma cells in bone marrow without evidence of paraprotein in circulation proved by low A/G ratio and
negative M-spike.
Keywords
Full Text:
PDFReferences
Lonial BS, Kaufman JL. Non-secretory myeloma: A
clinician ' s guide Review, 2019; 4-7.
Wei A. Bone marrow immunohistology of plasma cell
neoplasms. J Clin Pathol, 2003; 56(6): 406-11.
Aman AK. Profil penderita multiple myeloma di bagian
Patologi Klinik FK USU/RSUP H. Adam Malik Medan.
Maj Kedokt Nusant. 2005; 38(2): 176-9.
Ludwig H, Bolejack V, Crowley J, Bladé J, San Miguel J,
et al. Survival and years of life lost in different age
cohorts of patients with multiple myeloma. J Clin
Oncol, 2010; 28(9): 1599-605.
Whicher JT, Davies JD, Grayburn JA. Intact and
fragmented intracellular immunoglobulin in a case
of non secretory myeloma. J Clin Pathol, 1975; 28(1):
-9.
Middela S, Prakash K. Non-secretory multiple
myeloma. Arch Pathol Lab Med, 2009; 43(4): 408-11.
Palumbo A, Anderson K. From multiple myeloma. N
Engl J Med, 2010; 1-11.
Sharma A, Kaushal M, Chaturvedi NK, Yadav R.
Cytodiagnosis of multiple myeloma presenting as
orbital involvement: A case report. Cyto Journal,
; 3: 1-5.
Prasad R, Yadav RR, Singh A, Mathur SP, Mangal Y,
Singh M. Non-secretory multiple myeloma presenting
with diffuse sclerosis of affected bones interspersed
with osteolytic lesions. Br J Radiol, 2009; 82(974):
-31.
C a l d a s . N o n - s e c r e t o r y m y e l o m a o r l i g h t
chain-producing multiple myeloma: A case report.
J Med Cases, 2011; 2(3): 97-100.
Kyle RA, Rajkumar S V. Criteria for diagnosis, staging,
risk stratification and response assessment of multiple
myeloma. Leukemia, 2009; 23(1): 3-9.
Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J,
Merlini G, et al. International myeloma working group
updated criteria for the diagnosis of multiple
myeloma. Lancet Oncol [Internet]. 2014;15(12):
e538-48. Available from: http://dx.doi.org/10.1016/
S1470-2045(14)70442-5 (accessed 7 October, 2019).
Dupuis MM, Tuchman SA. Non-secretory multiple
myeloma: From biology to clinical management. Onco
Targets Ther, 2016; 9: 7583-90.
Corso A, Mangiacavalli S. Review articles
non-secretory myeloma: Ready for a new definition?.
Mediterr J Hematol Infect Dis [Internet]. 2017; 9(Mc):
Available from: www.mjhid.org (accessed 24
June, 2019).
Maimun Zulhaidah Arthamin, Nyi R. Wahidah BAS.
Myeloma multiple non-secretory. Clin Pathol and Med
Lab, 2012; 22(1): 99-103.
DOI: http://dx.doi.org/10.24293/ijcpml.v27i1.1575
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.